We are live on ! Find out more
EMG

ETF Managers Group Portfolio holdings

AUM $3.1B
1-Year Est. Return 17.12%
This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$4.98B
AUM Growth
-$67M
Cap. Flow
+$45.9M
Cap. Flow %
0.92%
Top 10 Hldgs %
23.75%
Holding
764
New
67
Increased
404
Reduced
223
Closed
63

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$72.3M
2
VRSN icon
VeriSign
VRSN
+$67.1M
3
ZS icon
Zscaler
ZS
+$66.3M
4
NET icon
Cloudflare
NET
+$56.6M
5
CRWD icon
CrowdStrike
CRWD
+$54.6M

Top Sells

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$46.3M
2
NABL icon
N-able
NABL
+$40.2M
3
SWI
SolarWinds Corporation Common Stock
SWI
+$37.9M
4
PING
Ping Identity Holding Corp.
PING
+$32M
5
CVLT icon
Commault Systems
CVLT
+$31.5M

Sector Composition

Rank Sector Weight
1 Technology 49.28%
2 Materials 17.18%
3 Healthcare 8.92%
4 Financials 6.61%
5 Industrials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICVX
651
DELISTED
Icosavax, Inc. Common Stock
ICVX
$63K ﹤0.01%
11,843
+44
+0.4% +$692
RDN icon
652
Radian Group
RDN
$4.82B
$62K ﹤0.01%
2,732
+49
+2% +$1.13K
CODX
653
Co-Diagnostics
CODX
$8.45M
$56K ﹤0.01%
295
+4
+1% +$828
GDYN icon
654
Grid Dynamics Holdings
GDYN
$647M
$55K ﹤0.01%
4,251
-1,062
-20% -$21.7K
COMP icon
655
Compass
COMP
$8.42B
$53K ﹤0.01%
6,704
+616
+10% +$4.85K
CVM icon
656
CEL-SCI Corp
CVM
$27.4M
$52K ﹤0.01%
438
+4
+0.9% +$651
ATOS icon
657
Atossa Therapeutics
ATOS
$25.7M
$51K ﹤0.01%
2,561
-2
-0.1% -$41
ANGI icon
658
Angi Inc
ANGI
$204M
$47K ﹤0.01%
797
+63
+9% +$4.59K
EGIO
659
DELISTED
Edgio, Inc. Common Stock
EGIO
$46K ﹤0.01%
220
-59
-21% -$9.84K
CUE icon
660
Cue Biopharma
CUE
$203M
$45K ﹤0.01%
321
+1
+0.3% +$212
PRTK
661
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$45K ﹤0.01%
15,224
+51
+0.3% +$192
IMV
662
DELISTED
IMV Inc. Common Shares
IMV
$45K ﹤0.01%
3,159
+661
+26% +$8.37K
CFRX
663
DELISTED
ContraFect Corporation
CFRX
$44K ﹤0.01%
149
– –
ENZ
664
DELISTED
Enzo Biochem, Inc.
ENZ
$43K ﹤0.01%
14,703
+52
+0.4% +$167
CDAK
665
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$43K ﹤0.01%
6,784
+23
+0.3% +$144
LHDX
666
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$43K ﹤0.01%
11,898
+43
+0.4% +$211
ATHX
667
DELISTED
Athersys, Inc. Common Stock
ATHX
$43K ﹤0.01%
2,854
+9
+0.3% +$188
SQZ
668
DELISTED
SQZ Biotechnologies Company
SQZ
$40K ﹤0.01%
8,513
+30
+0.4% +$190
SPRY icon
669
ARS Pharmaceuticals
SPRY
$586M
$37K ﹤0.01%
10,640
+35
+0.3% +$152
SABS icon
670
SAB Biotherapeutics
SABS
$345M
$34K ﹤0.01%
1,319
-1
-0.1% -$46
MTTR
671
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$34K ﹤0.01%
4,022
+1,000
+33% +$9.47K
OGN icon
672
Organon & Co
OGN
$3.61B
$33K ﹤0.01%
912
+21
+2% +$718
TNXP icon
673
Tonix Pharmaceuticals
TNXP
$233M
– –
0
– –
IFRX icon
674
InflaRx
IFRX
$329M
$32K ﹤0.01%
13,403
+49
+0.4% +$153
RDFN
675
DELISTED
Redfin
RDFN
$32K ﹤0.01%
1,690
+112
+7% +$2.88K
25 26
27
28 29

Similar funds

AIA
Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return
PFM
Parsec Financial Management Asheville, North Carolina $2.37B AUM 4.66% 1-Year Est. Return
DKP
Davidson Kempner Partners New York $5.16B AUM
HT
HighTower Trust Houston, Texas $1.02B AUM 4.1% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
QA
Quantitative Advantage Minnetonka, Minnesota $689M AUM 6.25% 1-Year Est. Return
BFG
Barber Financial Group Lenexa, Kansas $567M AUM 5.25% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return

ETF Managers Group's Q1 2022 Portfolio in Review

As of Q1 2022, ETF Managers Group held 764 positions worth $4.98B, down 1.3% from $5.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

ETF Managers Group's Q1 2022 filing shows 67 new, 404 increased, 223 reduced and 63 closed positions. Its largest new stake was Bank of New York Mellon: 78,337 shares worth $4.06M. The largest sale was Arena Pharmaceuticals Inc, an estimated $46.3M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, down from 50% a quarter earlier, followed by Materials and Healthcare.

  • ETF Managers Group's largest Q1 2022 buy was Bank of New York Mellon: 78,337 shares worth $4.06M.
  • ETF Managers Group added most to Okta in Q1 2022, an estimated $72.3M increase.
  • ETF Managers Group's biggest Q1 2022 reduction was N-able, cutting an estimated $40.2M.
  • ETF Managers Group fully exited Arena Pharmaceuticals Inc in Q1 2022, selling an estimated $46.3M.
  • ETF Managers Group's ten largest holdings make up 24% of its $4.98B portfolio in Q1 2022.
  • ETF Managers Group opened 67 new positions and closed 63 in Q1 2022.
  • ETF Managers Group's portfolio value fell 1.3% quarter-over-quarter to $4.98B.

Based on ETF Managers Group's 13F filing for Q1 2022, filed 13 May 2022.